Micro–RNA-126 Reduces the Blood Thrombogenicity in Diabetes Mellitus via Targeting of Tissue Factor
Marco Witkowski(Cleveland Clinic), Ursula Rauch-Kroehnert(Deutsches Herzzentrum der Charité), Bernd Stratmann(Heart and Diabetes Center North Rhine-Westphalia), Mario Witkowski(Leibniz Association), Daniel Steffens(The University of Sydney), Alice Weithäuser(Johannes Gutenberg University Mainz), Ulf Landmesser(Deutsches Herzzentrum der Charité), Termeh Tabaraie(Johannes Gutenberg University Mainz), Nicolle Kränkel(Leipzig Heart Institute), Diethelm Tschoepe(Heart and Diabetes Center North Rhine-Westphalia)
Cited by 80
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
|European Heart Journal|2016|3.2k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
2023 ESC Guidelines for the management of endocarditis
|European Heart Journal|2023|1.6k